| Company Announcements: (reported by the Company) |
No items found
|
| Elevator Pitch: | Cincera Therapeutics is a privately held biotechnology company based in Melbourne, Australia. The company is focused on the discovery and development of new drugs aiming to treat difficult-to-treat inflammatory and fibrotic conditions associated with obesity/metabolic diseases, with potential applications in many other disease areas including cancer. The company will initially focus on treatments for the emerging epidemic of a liver disease termed ‘NASH’ (non-alcoholic steatohepatitis). |
| Category: | Health & biotech |
| URL: | https://www.cinceratx.com/ |
| Operational Status: | Active |
| ASX Listing Code (if applicable): | |
| Year of Commencement: | 2018 |
| Address: | Melbourne, VIC |
| State: | Victoria |
| Overseas Operations: | No |
| X: | |
| Facebook: | |
| Linkedin: | https://www.linkedin.com/company/cincera-therapeutics-pty-ltd/ |
| Founders: | |
| Awards won: | |
